You are here

Allos

AMAG-Allos, a Match Made in Necessity

Motley Fool

Fri, 07/22/11 - 11:18 am

Amag Pharmaceuticals

Amag-Allos: Worst Bio-Merger in History

TheStreet.com

Wed, 07/20/11 - 11:43 am

Amag Pharmaceuticals

Vertex Pharma licenses 2 oral hepatitis C drug candidates from Alios BioPharma

Yahoo/AP

Mon, 06/13/11 - 10:06 am

Vertex Pharmaceuticals

Risk-Reward Balanced at Allos

Yahoo/Zacks

Sat, 05/21/11 - 11:00 am

1Q Loss Narrows at Allos

Yahoo/Zacks

Sat, 05/14/11 - 12:32 pm

Allos Therapeutics Evenly Poised

Yahoo/Zacks.com

Thu, 03/31/11 - 10:43 am

T-cell lymphoma

Allos Therapeutics: Comeback Stock of the Year?

Seeking Alpha

Tue, 03/29/11 - 11:37 am

Revenues Rise at Allos

Yahoo/Zacks

Sat, 03/5/11 - 12:08 pm

Allos: analysis shows lymphoma drug helped some patients who didn't respond to other therapies

Yahoo/AP

Thu, 01/20/11 - 02:15 pm

ALTH's Preliminary 4Q Sales Impress

Yahoo/Zacks.com

Thu, 01/13/11 - 01:31 pm

Allos reports $11.7 million in 4Q revenue

Yahoo/AP

Wed, 01/12/11 - 12:34 pm

ZIOP Initiates Cancer Study

Yahoo/Zacks.com

Thu, 12/30/10 - 10:58 am

Lessons From A Losing Biotech Portfolio

TheStreet.com

Mon, 11/29/10 - 11:38 am

Ariad Pharmaceuticals

Vertex Pharmaceuticals

Seattle Genetics

Human Genome Sciences

Spectrum Pharmaceuticals

Allos Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript

Seeking Alpha

Mon, 11/8/10 - 09:34 am

Allos gets added orphan drug status for Folotyn

Yahoo/AP

Fri, 10/15/10 - 12:29 pm

Hodgkin's lymphoma

Four Biotech Takeout Candidates

Forbes

Fri, 09/10/10 - 11:57 am

What Investors Think About Allos Therapeutics

Motley Fool

Thu, 07/29/10 - 10:35 am

Allos Therapeutics' Folotyn meets study goal

Yahoo/AP

Wed, 07/28/10 - 11:24 pm

Biotech Stock Mailbag: Exact Sciences

TheStreet.com

Fri, 07/23/10 - 07:16 am

Gilead Sciences

Cell Therapeutics

Volume Hunter: Cancer Stocks

Yahoo/IndieResearch

Wed, 07/14/10 - 10:49 am

Cell Therapeutics

Human Genome Sciences

Pages